These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25968152)

  • 1. Letter: systemic therapy for psoriasis could affect the prevalence of NAFLD.
    Tanoglu A; Beyazıt Y; Aydın E; Karagoz E
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1301. PubMed ID: 25968152
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases.
    Sartini A; Leonardi F; Gitto S; Di Girolamo M; Villa E
    Aliment Pharmacol Ther; 2015 Aug; 42(4):489. PubMed ID: 26179764
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
    Roberts KK; Cochet AE; Lamb PB; Brown PJ; Battafarano DF; Brunt EM; Harrison SA
    Aliment Pharmacol Ther; 2015 Feb; 41(3):293-300. PubMed ID: 25521607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.
    Gisondi P; Barba E; Girolomoni G
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):282-7. PubMed ID: 26537011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Prevalence of NAFLD in IBD Patients.
    Gaidos JKJ; Fuchs M
    Dig Dis Sci; 2017 May; 62(5):1362. PubMed ID: 28357696
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
    Abedini R; Salehi M; Lajevardi V; Beygi S
    Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
    Madanagobalane S; Anandan S
    Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
    J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and Nonalcoholic Fatty Liver Disease.
    Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
    Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Gisondi P; Targher G; Zoppini G; Girolomoni G
    J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The linkage between psoriasis and non-alcoholic fatty liver disease: a literature review.
    Ramos AN; de Oliveira Rocha B; de Almeida Rêgo VR; Follador I; de Oliveira MF
    Acta Dermatovenerol Croat; 2014; 22(2):132-6. PubMed ID: 25102800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X; Su L; Gao Y; Ding Y
    PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease, alcohol intake and psoriasis.
    Bordignon M; Viel G; Peserico A; Alaibac M
    J Hepatol; 2010 Sep; 53(3):587. PubMed ID: 20561701
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
    Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
    Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.